Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.21%601.09M | 2.54%572.73M | -0.02%543.65M | 15.34%2.21B | 6.24%542.01M | 11.00%560.69M | 18.88%558.56M | 27.48%543.78M | 32.39%1.91B | 27.11%510.19M |
| Operating revenue | 7.21%601.09M | 2.54%572.73M | -0.02%543.65M | 15.34%2.21B | 6.24%542.01M | 11.00%560.69M | 18.88%558.56M | 27.48%543.78M | 32.39%1.91B | 27.11%510.19M |
| Cost of revenue | 3.89%373.09M | -0.54%356.64M | -3.66%342.87M | 16.06%1.42B | 3.19%347.53M | 10.46%359.12M | 20.58%358.56M | 34.19%355.88M | 44.43%1.22B | 36.04%336.78M |
| Gross profit | 13.11%228M | 8.04%216.09M | 6.86%200.79M | 14.07%783.96M | 12.15%194.49M | 11.99%201.57M | 15.94%200M | 16.45%187.9M | 15.27%687.27M | 12.75%173.41M |
| Operating expense | 0.23%68.43M | 14.47%72.4M | 5.92%67.92M | 14.27%268.3M | 5.96%72.65M | 24.72%68.27M | 18.57%63.25M | 10.29%64.12M | 26.24%234.79M | 29.73%68.57M |
| Selling and administrative expenses | -5.37%43.85M | 15.27%48.25M | 3.46%44.35M | 15.82%180.14M | 2.19%49.08M | 34.41%46.34M | 23.42%41.86M | 9.58%42.87M | 35.19%155.54M | 40.66%48.02M |
| -General and administrative expense | -5.37%43.85M | 15.27%48.25M | 3.46%44.35M | 15.82%180.14M | 2.19%49.08M | 34.41%46.34M | 23.42%41.86M | 9.58%42.87M | 35.19%155.54M | 40.66%48.02M |
| Depreciation amortization depletion | 12.05%24.58M | 12.90%24.14M | 10.89%23.57M | 11.23%88.16M | 14.76%23.58M | 8.25%21.94M | 10.11%21.39M | 11.75%21.26M | 11.72%79.25M | 9.78%20.54M |
| -Depreciation and amortization | 12.05%24.58M | 12.90%24.14M | 10.89%23.57M | 11.23%88.16M | 14.76%23.58M | 8.25%21.94M | 10.11%21.39M | 11.75%21.26M | 11.72%79.25M | 9.78%20.54M |
| Operating profit | 19.71%159.58M | 5.07%143.69M | 7.35%132.87M | 13.96%515.66M | 16.21%121.84M | 6.42%133.3M | 14.76%136.75M | 19.92%123.77M | 10.30%452.48M | 3.86%104.85M |
| Net non-operating interest income (expenses) | 0 | 0 | 50.07%-1.52M | 0 | 0 | 4.23%-724K | -7.31%-793K | -7.63%-3.04M | -4.40%-772K | |
| Non-operating interest expense | ---- | --0 | --0 | -50.07%1.52M | --0 | --0 | -4.23%724K | 7.31%793K | 7.63%3.04M | 4.40%772K |
| Other net income (expenses) | -86.98%87K | 71.87%-238K | 3.61M | -19.51%-588K | 37.88%-410K | 265.03%668K | -261.76%-846K | 80.08%-492K | -47.09%-660K | |
| Gain on sale of security | -86.98%87K | 71.87%-238K | --3.61M | -19.51%-588K | 37.88%-410K | 265.03%668K | -261.76%-846K | ---- | 80.08%-492K | -47.09%-660K |
| Income before tax | 19.18%159.66M | 6.11%143.45M | 10.97%136.47M | 14.39%513.56M | 17.42%121.43M | 7.46%133.97M | 13.67%135.18M | 20.65%122.98M | 10.87%448.95M | 3.66%103.41M |
| Income tax | -2.74%34.43M | -4.32%31.08M | 17.35%34.22M | 22.33%126.42M | 34.44%29.37M | 23.36%35.4M | 9.91%32.49M | 25.45%29.16M | 0.25%103.35M | -6.87%21.85M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 27.06%125.23M | 9.41%112.37M | 8.99%102.25M | 12.02%387.14M | 12.86%92.06M | 2.70%98.57M | 14.91%102.7M | 19.23%93.82M | 14.50%345.6M | 6.90%81.57M |
| Net income continuous operations | 27.06%125.23M | 9.41%112.37M | 8.99%102.25M | 12.02%387.14M | 12.86%92.06M | 2.70%98.57M | 14.91%102.7M | 19.23%93.82M | 14.50%345.6M | 6.90%81.57M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 27.06%125.23M | 9.41%112.37M | 8.99%102.25M | 12.02%387.14M | 12.86%92.06M | 2.70%98.57M | 14.91%102.7M | 19.23%93.82M | 14.50%345.6M | 6.90%81.57M |
| Preferred stock dividends | -59.02%7.22M | 0 | -67.32%1.43M | -35.89%2.87M | -32.79%2.92M | -14.79%17.63M | -1.89%4.42M | |||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 28.93%125.23M | 12.56%112.37M | 12.49%102.25M | 15.84%379.92M | 19.33%92.06M | 6.06%97.13M | 17.59%99.83M | 22.27%90.9M | 16.66%327.97M | 7.45%77.15M |
| Diluted earnings per share | 29.17%0.31 | 7.69%0.28 | 8.70%0.25 | 14.29%0.96 | 15.00%0.23 | 0.00%0.24 | 18.18%0.26 | 21.05%0.23 | 18.75%0.84 | 10.58%0.2 |
| Basic earnings per share | 29.17%0.31 | 12.00%0.28 | 8.70%0.25 | 15.85%0.95 | 21.05%0.23 | 4.35%0.24 | 19.05%0.25 | 27.78%0.23 | 18.39%0.82 | 5.12%0.19 |
| Dividend per share | 5.17%0.0934 | 8.44%0.095 | 2.28%0.0908 | 13.53%0.3558 | 0.14%0.0906 | 20.73%0.0888 | 16.10%0.0876 | 20.12%0.0888 | 24.09%0.3134 | 22.77%0.0905 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.